K R Vadalia’s scientific contributions

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (4)


Figure 2: FTIR Spectra of Amoxicillin trihydrate
Table 2 : In vitro drug release profile of various formulations *
Table 3 : Technological characterization for mucoadhesion in vitro wash-off test
Table 4 : Technological characterization for Swelling Ratio Entrapment Efficiency of various formulations
Table 5 : In vitro release kinetic data for various formulations

+1

Pharmaceutical characterization of amoxicillin trihydrate as mucoadhesive microspheres in management of H. pylori
  • Data
  • File available

March 2010

·

1,329 Reads

·

6 Citations

International Journal of PharmTech Research

S K Singh

·

·

·

[...]

·

Shree H N Shukla

Helicobacter pylori (H. pylori) infect more than half of the world population, making it one of the most prevalent infections. H. pylori is now accepted as the most common cause of histologic gastritis and is responsible for the majority of cases of peptic ulcer disease and gastric cancer. Approximately 1 in 6 (17%) persons with H. pylori infection will develop peptic ulcer disease, and each year 1% to 2% of these will experience a major or life-threatening complication, and this basically occurs due to short gastric residence time of antimicrobial agents, keeping that in mind mucoadhesive microspheres were prepared to increase gastric residence time using solvent evaporation method. The (mucoadhesive) sustained release of amoxicillin trihydrate is desired because of its short biological half-life. Predominantly to treat H. pylori infections, the mucoadhesive is desired to be confined to the upper gastrointestinal tract. Amoxicillin trihydrate mucoadhesive microspheres were prepared using Eudragit RS100 as matrix and HPMC K4M as mucoadhesive polymer for the potential use of treating gastric and duodenal ulcers, which were associated with H.pylori. The morphological characteristics of the mucoadhesive microspheres were studied under scanning electron microscope. The percentage yield of microspheres of all formulation was in the range of 78.90% to 90.95%. The drug content determination showed that even if the polymer composition was changed the solvent evaporation process was highly efficient to give microspheres having maximum drug loading. In termination, the prolonged gastrointestinal residence time and enhanced amoxicillin trihydrate stability resulting from the mucoadhesive microspheres of amoxicillin trihydrate might make contribution to H. pylori clearance.

Download

Figure 2: FTIR Spectra of Amoxicillin trihydrate
In vitro drug release profile of various formulations *
In vitro release kinetic data for various formulations
PHARMACEUTICAL CHARACTERIZATION OF AMOXICILLIN TRIHYDRATE AS MUCOADHESIVE MICROSPHERES IN MANAGEMENT OF H. PYLORI

January 2010

·

526 Reads

·

3 Citations

Helicobacter pylori (H. pylori) infect more than half of the world population, making it one of the most prevalent infections. H. pylori is now accepted as the most common cause of histologic gastritis and is responsible for the majority of cases of peptic ulcer disease and gastric cancer. Approximately 1 in 6 (17%) persons with H. pylori infection will develop peptic ulcer disease, and each year 1% to 2% of these will experience a major or life-threatening complication, and this basically occurs due to short gastric residence time of antimicrobial agents, keeping that in mind mucoadhesive microspheres were prepared to increase gastric residence time using solvent evaporation method. The (mucoadhesive) sustained release of amoxicillin trihydrate is desired because of its short biological half-life. Predominantly to treat H. pylori infections, the mucoadhesive is desired to be confined to the upper gastrointestinal tract. Amoxicillin trihydrate mucoadhesive microspheres were prepared using Eudragit RS100 as matrix and HPMC K4M as mucoadhesive polymer for the potential use of treating gastric and duodenal ulcers, which were associated with H.pylori. The morphological characteristics of the mucoadhesive microspheres were studied under scanning electron microscope. The percentage yield of microspheres of all formulation was in the range of 78.90% to 90.95%. The drug content determination showed that even if the polymer composition was changed the solvent evaporation process was highly efficient to give microspheres having maximum drug loading. In termination, the prolonged gastrointestinal residence time and enhanced amoxicillin trihydrate stability resulting from the mucoadhesive microspheres of amoxicillin trihydrate might make contribution to H. pylori clearance.


Figure 3: in vitro dissolution profile of Diclofenac sodium tablets prepared with seed mucilage of Cassia auriculata as binding agent.
Composition of Tablet Formulation
Data Showing, Preliminary Phytochemical Screening of Isolated Mucilage
Preliminary evaluation of Cassia auriculata seed mucilage as binding agent

December 2009

·

105 Reads

·

4 Citations

Pharmacognosy Journal

Cassia auriculata is a tropical tree locally belonging to the family Caesalpiniaceae found widely in India. Seeds of plant contain gluco-mannose hence attempt to evaluate the seeds for suitability as tablet binder is considered and the present investigation reports the isolation of mucilage of Cassia auriculata seed. The DSC and FTIR thermograms of drug and gum indicated no chemical interaction. Phytochemical characteristics of mucilage, such as carbohydrate, protein and flavanoids etc. were studied. Physiochemical characteristics of mucilage, such as solubility, swelling index, loss on drying, viscosity, hydration capacity, powder porosity, microbiological properties and pH were studied. The mucilage was evaluated for its granulating and binding properties in compressed tablet, using Diclofenac sodium as model drug. Mucilage was used in four different concentration i.e. 0.25, 0.5, 0.75 and 1.0% w/v. The granules were prepared by wet granulation process. The prepared granules were evaluated for percentage of fines, average particle size, compressibility index and flow properties. The properties were compared with Guar gum, which was used as standard binder at 1.00% w/v concentration. The tablet were prepared and evaluated for content uniformity, hardness, friability, disintegration time and in vitro dissolution profile. The tablets had good physiochemical properties, and the drug release was more than 85% within 3 hour. It was observed that increasing the concentration of mucilage increases hardness and decreases the disintegration time. All the formulations (F1, F2, F3, F4 and F5) were subjected to stability studies for three months at 25° C/60% RH, 30° C/65% RH and 40° C/75% RH as per ICH guidelines, only F1 and F2 showed stability with respect to release pattern and other parameters which confirm the use of mucilage as excipient.


Effect of Hemidesmus indicus Aqueous & Methanolic Extract on Organ weight to body weight ratio
Possible Role of Natural Nephroprotective; Hemidesmus indicus in Congestive Heart Failure

January 2009

·

48 Reads

·

9 Citations

Pharmacognosy Research

Hemidesmus indicus R.Br. is a treasure of the forest and herbal wealth. It is being used as folk medicines and as an ingredient in Ayurveda and Unani preparations against diseases of blood, inflammation, diarrhea, urinary disorders and rheumatism etc. The objective of the present study was to evaluate the role of natural nephroprotectant Hemidesmus indicus for the treatment of congestive heart failure. Hemidesmus indicus extracts were evaluated by using salt water induced left ventricular hypertrophy in Spargue dawley rat model. The property was evaluated using serum creatinine, urea, SGOT, SGPT and urine albumin, creatinine, Na+, K+ and Ca++ as biochemical parameters and histopathological changes including myocyte diameter, neutrophil infiltration and cardiac hypertrophy. Results obtained from the present study indicates that aqueous and methanolic extracts have more significant inhibitory effect on salt water feeding induced severity of microalbuminuria, serum urea and creatinine, myocyte diameter and retention of Na+ and water and increases the serum calcium level. We conclude from the present study that, potent natural nephroprotectant Hemidesmus indicus is also a potent cardioprotective.

Citations (4)


... reported that an aqueous root extract of H. indicus exhibited nephroprotective activity in male albino Wistar rats, with a dosage of 100 mg/kg resulting in reduced tubular degeneration and dilatation after 19 hours of observation. Sudarshan and Patel (2009) [49] investigated the cardioprotective activity of aqueous and methanolic root extracts, using SD rats with dosages of 100, 200, and 400 mg/kg. They found that after 6 weeks, creatinine was reduced. ...

Reference:

Nutritional, pharmacological activities and food application of nannari root: A review
Possible Role of Natural Nephroprotective; Hemidesmus indicus in Congestive Heart Failure

Pharmacognosy Research

... Due to the near neutrality of the pH value, it may be less irritating in gastrointestinal tract and hence suitable for uncoated tablets. 17,18 Pre-compression Evaluation The prepared granules were evaluated for various pre-compession parameters which include bulk density, tapped density, Carr's index, Hausner's ratio and Angle of repose. Results of the pre-compression parameters performed are shown in Table 5. ...

Preliminary evaluation of Cassia auriculata seed mucilage as binding agent

Pharmacognosy Journal

... The spectral analysis shows that in the FTIR spectra of MCCh M1 and MCCh-Fb M4 films in the presence of bioactive substances (AM and PDGF-BB) predominated bands characteristic of MCCh; therefore, it is difficult to determine the appearance or disappearance of any of the characteristic peaks of pure substance in film, although disappearance of the bands at ca. 1080 cm −1 , 980 cm −1 , and 860 cm −1 characteristic for PDGF-BB and Am can be observed. In presence of Am, spectra M1 and M4 do not show any visible shift of the bands characteristic for MCCh, but a weak new band at ca. 1520 cm −1 characteristic of Am [48] can be observed, which confirms the weak intermolecular interaction between drug and polymer. ...

Pharmaceutical characterization of amoxicillin trihydrate as mucoadhesive microspheres in management of H. pylori

International Journal of PharmTech Research

... Albeit a different dosage form, this time frame is also much longer compared to the Singh et al.study(5), where release of amoxicillin from microspheres was sustained by/through a mucoadhesive device. Their best formulation, based on a combination of HPMC K4M as mucoadhesive and Eudragit RS 100 as polymer matrix, showed a continuous release over amaximum of 12 h only in-vitro, with the release profile reaching 96.15 w/w% of the total amount in that relatively short period. ...

PHARMACEUTICAL CHARACTERIZATION OF AMOXICILLIN TRIHYDRATE AS MUCOADHESIVE MICROSPHERES IN MANAGEMENT OF H. PYLORI